Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10004680HBVENSG00000092969.12protein_codingTGFB2NoNo7042P61812
TVIS10004679HBVENSG00000092969.12protein_codingTGFB2NoNo7042P61812
TVIS10062475HBVENSG00000092969.12protein_codingTGFB2NoNo7042P61812
TVIS20016736HPVENSG00000092969.12protein_codingTGFB2NoNo7042P61812
TVIS20048124HPVENSG00000092969.12protein_codingTGFB2NoNo7042P61812
TVIS20017383HPVENSG00000092969.12protein_codingTGFB2NoNo7042P61812
TVIS44037081HTLV-1ENSG00000092969.12protein_codingTGFB2NoNo7042P61812
TCGA Plot Options
Drug Information
GeneTGFB2
DrugBank IDDB05697
Drug NameTrabedersen
Target IDBE0003481
UniProt IDP61812
Regulation Type
PubMed IDs16377233
CitationsSchlingensiepen KH, Schlingensiepen R, Steinbrecher A, Hau P, Bogdahn U, Fischer-Blass B, Jachimczak P: Targeted tumor therapy with the TGF-beta 2 antisense compound AP 12009. Cytokine Growth Factor Rev. 2006 Feb-Apr;17(1-2):129-39. Epub 2005 Dec 27.
GroupsInvestigational
Direct Classification
SMILES
Pathways
PharmGKB
ChEMBL